Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Pets at Home Group (PETS) by Gordon Best in The Motley Fool
- Buy The Character Group (CCT) by Hot Stock Rockets in ShareProphets
- Sell Fusion Antibodies (FAB) by Steve Moore in ShareProphets
- Sell Light Science Technologies Holdings (LST) by Steve Moore in ShareProphets
- Neutral Severn Trent (SVT) by JP Morgan
- Top Pick National Grid (NG.) by JP Morgan
- Overweight Centrica (CNA) by JP Morgan
- Overweight SSE (SSE) by JP Morgan
- Overweight Persimmon (PSN) by JP Morgan
- Overweight Taylor Wimpey (TW.) by JP Morgan
- Overweight Barratt Developments (BDEV) by JP Morgan
- Overweight United Utilities Group (UU.) by JP Morgan
- Neutral Berkeley Group Holdings (The) (BKG) by JP Morgan
- Neutral Bellway (BWY) by JP Morgan
- Overweight Drax Group (DRX) by JP Morgan
- Neutral Pennon Group (PNN) by JP Morgan
- Underweight Crest Nicholson Holdings (CRST) by JP Morgan
- Neutral Redrow (RDW) by JP Morgan
- Buy M&C Saatchi (SAA) by Shore Capital
- Buy Hostelworld Group (HSW) by Shore Capital
Poolbeg Pharma (POLB) Share Price
Health Care Sector
NOTE: This is based on 2 open tips for Poolbeg Pharma (POLB)
| Latest Bid : 13.60p | Latest Ask : 14.00p |
| High Today : 13.95p | Low Today : 13.10p |
| This Years High : 14.90p | This Years Low : 6.55p |
| Volume : 1,136,173 | MKT Cap : £69M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Poolbeg Pharma (POLB) Overview
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire.Poolbeg Pharma (POLB) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Watch | Edward Sheldon | Premium Only | 2024-05-15 09:45:00 15/05/2024 | – |
| Buy | Joanne Hart | Premium Only | 2021-08-22 14:55:00 22/08/2021 | 51.65% |
Poolbeg Pharma (POLB) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 13.60p | Latest Ask : 14.00p |
| High Today : 13.95p | Low Today : 13.10p |
| This Years High : 14.90p | This Years Low : 6.55p |
| Volume : 1,136,173 | MKT Cap : £69M |
Poolbeg Pharma Overview
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Poolbeg Pharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Watch | Edward Sheldon | Premium Only | 2024-05-15 09:45:00 15/05/2024 | – |
| Buy | Joanne Hart | Premium Only | 2021-08-22 14:55:00 22/08/2021 | 51.65% |